Melanotan II

Also known as: MT-2, MT2

A melanocortin peptide for tanning and sexual function enhancement.

Overview

Melanotan II is a synthetic analog of alpha-melanocyte stimulating hormone that causes skin tanning and has sexual arousal effects. PT-141 was developed from this peptide.

Mechanism of Action

Non-selective melanocortin receptor agonist. MC1R activation causes tanning. MC3R/MC4R activation in brain affects sexual function and appetite.

Pharmacokinetics

Half-life 30-60 minutes. Tanning effects cumulative over days. Sexual effects acute.

Dosing Protocols

Note: These are research protocols from literature. This is not medical advice.

1

Loading

Dose

250-500 mcg

Frequency

Daily

Duration

1-2 weeks

Until desired tan; nausea common initially

2

Maintenance

Dose

250-500 mcg

Frequency

1-2x weekly

Duration

As needed

Maintain tan; sun exposure enhances effect

Research Areas

Skin TanningSexual DysfunctionAppetite Regulation

Key Research Findings

  • 1Produces significant skin tanning
  • 2Enhances sexual arousal and erection
  • 3Reduces appetite in some users
  • 4Led to development of FDA-approved PT-141

Side Effects & Contraindications

Reported Side Effects

  • Nausea
  • Facial flushing
  • Fatigue
  • Spontaneous erections
  • Mole darkening

Contraindications

  • History of melanoma
  • Many moles
  • Cardiovascular disease

Safety Considerations

Not FDA-approved. May cause nausea, facial flushing, mole changes. Risk of melanoma acceleration is debated. Cardiovascular effects possible.

Storage Requirements

Store lyophilized at -20C. Reconstituted at 2-8C.

Scientific References

Quick Reference

Sequence
Ac-Nle-cyclo[Asp-His-D-Phe-Arg-Trp-Lys]-NH2
Molecular Weight
1024.2 g/mol
Half-Life
30-60 minutes
Bioavailability
High (SC)
Research Stage
clinical phase 2
Administration
Subcutaneous injection